70OA phase Ia/Ib trial of tislelizumab, an anti-PD-1...

Annals of Oncology 2018 / 12 Vol. 29; Iss. suppl_10

70OA phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors

Deva, S, Lee, J-S, Lin, C-C, Yen, C-J, Millward, M, Chao, Y, Keam, B, Jameson, M, Hou, M-M, Kang, Y-K, Markman, B, Lu, C-H, Rau, K-M, Lee, K-H, Horvath, L, Friedlander, M, Hill, A, Wu, J, Hou, J, Desa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy487.042
Date:
December, 2018
File:
PDF, 114 KB
2018
Conversion to is in progress
Conversion to is failed